Nischal K. Gautam

Nischal K. Gautam

Auto-generated profile, based on publicly available information

Nischal K. Gautam

Department of Anesthesiology, The University of Texas Medical School, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NGNischal K. Gautam
Nischal K. Gautam
YTYuliya Turiy
Yuliya Turiy
CSChandra Srinivasan
Chandra Srinivasan

30 November 2016 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
NGNischal K. Gautam
Nischal K. Gautam
CCChunyan Cai
Chunyan Cai
OPOlga Pawelek
Olga Pawelek
MRMuhammad B. Rafique
Muhammad B. Rafique
DCDavide Cattano
Davide Cattano
EPEvan G. Pivalizza
Evan G. Pivalizza

15 June 2017 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
NGNischal K. Gautam
Nischal K. Gautam
KBKayla R. Bober
Kayla R. Bober
CCChunyan Cai
Chunyan Cai

13 December 2019 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
PDF file
NGNischal K. Gautam
Nischal K. Gautam
JPJames Pierre
James Pierre
KEKayla Edmonds
Kayla Edmonds
OPOlga Pawelek
Olga Pawelek
EGEvelyn Griffin
Evelyn Griffin
JSJorge Salazar
Jorge Salazar
In neonates, transfusion of platelets after hemodilution from cardiopulmonary bypass (CPB) has been standard. We hypothesize that platelet administration during the rewarming phase before termination of CPB would reduce coagulopathy, enhance hemostasis, reduce transfusion, and improve postoperative outcomes after neonatal cardiac surgery. A prospective, randomized trial was performed in 46 neonates. Controls received platelets only at the end of bypass with other blood products to assist in hemostasis. The treatment group received 10 mL/kg of platelets during the rewarming phase of bypass after cross-clamp release. After protamine, transfusion and perioperative management protocols were identical and constant among groups. Two neonates in each group were excluded secondary to postoperative need for extracorporeal support. Controls (n = 21) and treatment patients (n = 21) were similar in age, weight, case complexity, associated syndromes, single ventricle status, and CPB times. Compared to controls, the treatment group required 40% less postbypass blood products (58 ± 29 vs 103 ± 80 mL/kg, P = .04), and case completion time after protamine administration was 28 minutes faster (P = .016). The treatment group required fewer postoperative mediastinal explorations for bleeding (P = .045) and had a lower fluid balance (P = .04). The treatment group had shorter mechanical ventilation (P = .016) and length of intensive care unit times (P = .033). There were no 30-day mortalities in either group. Platelet transfusion during the rewarming phase of neonatal cardiac surgery was associated with reduced bleeding and improved postoperative outcomes, compared to platelets given after coming off bypass. Further studies are necessary to understand mechanisms and benefits of this strategy.

2 January 2013 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
NGNischal K. Gautam
Nischal K. Gautam
MSMichael L. Schmitz
Michael L. Schmitz
DHDale Harrison
Dale Harrison
LZLuis M. Zabala
Luis M. Zabala
PKPamela Killebrew
Pamela Killebrew
DNDaniel C. Norvell
Daniel C. Norvell

10 February 2020 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
RHRichard Hubbard
Richard Hubbard
KEKayla Edmonds
Kayla Edmonds
EREric Rydalch
Eric Rydalch
OPOlga Pawelek
Olga Pawelek
EGEvelyn Griffin
Evelyn Griffin
NGNischal Gautam
Nischal Gautam